Hangzhou Biotest Biotech Co.,Ltd. (SHA:688767)

China · Delayed Price · Currency is CNY

42.56

-0.86 (-1.98%)

May 12, 2026, 3:00 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
In Vitro Diagnostic Test Paper		559.40M	442.11M	1.90B	1.82B	865.37M
In Vitro Diagnostic Test Paper Growth		26.53%	-76.75%	4.57%	110.09%	314.37%
Total		559.40M	442.11M	1.90B	1.82B	865.37M
Total Growth		26.53%	-76.75%	4.57%	110.09%	314.37%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
China		129.35M	-	-	-	-
Overseas		430.05M	-	-	-	-
Total		559.40M	-	-	-	-

Source: S&P Global Market Intelligence.